TP53 and myelodysplastic syndrome: Regarding the clinical cases of elevated RPL23 expression in higher-risk MDS patients, the two opposing roles of RPL23 in cellular apoptosis might be the result of heterogeneity in individual cells and disease stages in different MDS patients, an effect that is complicated by different karyotype abnormalities and p53 mutation scenarios.